In adaptive cellular immune response patients with COVID-19 show a dramatic reduction in total T cells, which is negatively related to patient survival; these T cells express exhaustive signatures, such as PD-1, TIM-3, and LAG-3 [91, 92], all of which are immune-inhibitory factors [93, 94]. The gene discussed is HAVCR2; the disease is COVID-19.